Oramed Pharmaceuticals ORMP Stock
$4.36
-0.683365%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$178.44M
LOW - HIGH [24H]
$4.22
-
$4.43
VOLUME [24H]
$128.67K
P/E Ratio
1.55
Earnings per share
$2.80
ISIN
US68403P2039
Oramed Pharmaceuticals Price Chart
Oramed Pharmaceuticals ORMP Financial and Trading Overview
| Oramed Pharmaceuticals stock price | 4.36 USD |
| Previous Close | 4.07 USD |
| Open | 4.11 USD |
| Bid | 3.01 USD x 200 |
| Ask | 5.27 USD x 200 |
| Day's Range | 4.07 - 4.26 USD |
| 52 Week Range | 1.98 - 5.19 USD |
| Volume | 103.75K USD |
| Avg. Volume | 298.01K USD |
| Market Cap | 173.94M USD |
| Beta (5Y Monthly) | 1.201 |
| PE Ratio (TTM) | 1.6346154 |
| EPS (TTM) | 2.8 USD |
| Forward Dividend & Yield | 0.25 (6.13%) |
| Ex-Dividend Date | January 16, 2026 |
| 1y Target Est | 6.25 USD |
ORMP Valuation Measures
| Enterprise Value | 101.49M USD |
| Trailing P/E | 1.6346154 |
| Forward P/E | -53.125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | |
| Price/Book (mrq) | 0.7299897 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.185 |
Trading Information
Oramed Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.201 |
| 52-Week Change | 94.73% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 5.19 USD |
| 52 Week Low | 1.98 USD |
| 50-Day Moving Average | 4.09 USD |
| 200-Day Moving Average | 3.44 USD |
ORMP Share Statistics
| Avg. Volume (3 month) | 298.01K USD |
| Avg. Daily Volume (10-Days) | 147.93K USD |
| Shares Outstanding | 40.93M |
| Float | 31.59M |
| Short Ratio | 1.5 |
| % Held by Insiders | 17.93% |
| % Held by Institutions | 32.63% |
| Shares Short | 765.36K |
| Short % of Float | 2.20% |
| Short % of Shares Outstanding | 1.87% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.0962 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -4.27% |
| Return on Equity (ttm) | 58.15% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 0 USD |
| EBITDA | -14126000 USD |
| Net Income Avi to Common (ttm) | 109.19M USD |
| Diluted EPS (ttm) | 2.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 65.84M USD |
| Total Cash Per Share (mrq) | 1.61 USD |
| Total Debt (mrq) | 761K USD |
| Total Debt/Equity (mrq) | 0.32 USD |
| Current Ratio (mrq) | 6.452 |
| Book Value Per Share (mrq) | 5.822 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8541000 USD |
| Levered Free Cash Flow (ttm) | 250.63K USD |
Profile of Oramed Pharmaceuticals
| Country | United States |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 844 967 2633 |
| Website | https://oramed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Q&A For Oramed Pharmaceuticals Stock
What is a current ORMP stock price?
Oramed Pharmaceuticals ORMP stock price today per share is 4.36 USD.
How to purchase Oramed Pharmaceuticals stock?
You can buy ORMP shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oramed Pharmaceuticals?
The stock symbol or ticker of Oramed Pharmaceuticals is ORMP.
Which industry does the Oramed Pharmaceuticals company belong to?
The Oramed Pharmaceuticals industry is Biotechnology.
How many shares does Oramed Pharmaceuticals have in circulation?
The max supply of Oramed Pharmaceuticals shares is 40.93M.
What is Oramed Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Oramed Pharmaceuticals PE Ratio is 1.55714300 now.
What was Oramed Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Oramed Pharmaceuticals EPS is 2.8 USD over the trailing 12 months.
Which sector does the Oramed Pharmaceuticals company belong to?
The Oramed Pharmaceuticals sector is Healthcare.
Oramed Pharmaceuticals ORMP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26588.92 USD — |
+2.6
|
5.91B USD — | 26088.04 USD — | 26636.4 USD — | — - | 5.91B USD — |
|
US Tech Composite Total Return
XCMP
US
|
32811.34 USD — |
+2.63
|
— — | 32186.23 USD — | 32862.77 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
141.32 USD — |
+2.72
|
— — | 138.85 USD — | 141.58 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1259.79 USD — |
+1.49
|
— — | 1242.12 USD — | 1260.64 USD — | — - | — — |
- {{ link.label }} {{link}}
